Deferasirox
NDC 69238-1487, Deferasirox, tablet, film coated, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-1487
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210727
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1487 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX180 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-1487-3 | 69238148703 | 30 TABLET, FILM COATED in 1 BOTTLE (69238-1487-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a7ae9c31-e14f-4cf9-9ab3-850519f1a87c
Use it
Look up 69238-1487 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1487 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-1487. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.